Abstract
Paragangliomas are neuroendocrine tumors that have the potential to secrete catecholamines. They have been linked to genetic mutations in the mitochondrial succinate dehydrogenase (SDH) complex. Patients can experience both physical symptoms and psychiatric symptoms like anxiety, depression, and psychosis. These symptoms can occur as paroxysmal episodes with periods of increased catecholamine secretion. We describe a patient with SDHB gene mutation, who has been diagnosed with a jugular paraganglioma, and was brought to the hospital under Baker Act for threats made online. Since diagnosis this patient has been experiencing both anxiety and post-traumatic stress disorder (PTSD). The patient and a family member report increased emotional lability, and the patient reports multiple daily episodes of anxiousness. This case outlines the connection between paragangliomas and psychiatric symptoms, the impact they can have on patients’ daily lives, and the importance of addressing the possibility of these symptoms and establishing a multispecialty healthcare team at the time of diagnosis.
References
W.F. Young, P.Y. Wen: Paragangliomas: Epidemiology, Clinical Presentation, Diagnosis, and Histology. In: UpToDate, S. Shah (ed.), UpToDate, Waltham (2023).
N. Páez, M. Isabel, et al. Paraganglioma Neuroendocrine Tumor and Psychiatric Implications. A Case Report. Psiquiatría Biológica. (2021). https://doi.org/10.1016/j.psiq.2020.10.005.
E.F. Hensen, J.P. Bayley. Recent Advances in the Genetics of SDH-Related Paraganglioma and Pheochromocytoma. Familial Cancer. (2010). https://doi.org/10.1007/s10689-010-9402-1.
D.E. Benn, et al. Clinical Presentation and Penetrance of Pheochromocytoma/Paraganglioma Syndromes. J. Clin. Endocrinol. Metab. (2006). https://doi.org/10.1210/jc.2005-1862.
M. Bonomaully et al. Anxiety and Depression Related to Elevated Dopamine in a Patient with Multiple Mediastinal Paragangliomas. General Hospital Psych. (2014). https://doi.org/10.1016/j.genhosppsych.2014.03.003.
B. Havekes, et al. Reduced Quality of Life in Patients with Head-and-Neck Paragangliomas. Eur. J. Endocrinol. (2008). https://doi.org/10.1530/eje-07-0464.
A. Ikram, A. Rehman. Paraganglioma. In: StatPearls. StatPearls Publishing, Treasure Island (2023)
A. La Salvia, et al. Serotoninergic brain dysfunction in neuroendocrine tumor patients: A scoping review. Comprehensive Psych. (2021). https://doi.org/10.1016/j.comppsych.2021.152244.
J. Guilmette, P.M. Sadow. A Guide to Pheochromocytomas and Paragangliomas. Surg. Pathol. Clinics. (2019). https://doi.org/10.1016/j.path.2019.08.009.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by J.W., J.R., J.K., F.C. and E.K. The first draft of the manuscript was written by J.W., J.R., and J.K. and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Consent to participate
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
White, J.A., Rodriguez, J., Kandadai, J. et al. Increased anxiety and emotional lability in a patient with SDHB gene mutation paraganglioma: a call to multidisciplinary approach. Endocrine 83, 349–352 (2024). https://doi.org/10.1007/s12020-023-03555-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-023-03555-9